DOI QR코드

DOI QR Code

Nodal Outcomes of Uniportal versus Multiportal Video-Assisted Thoracoscopic Surgery for Clinical Stage I Lung Cancer

  • Choi, Jung Suk (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jiyun (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Young Kyu (Department of Thoracic and Cardiovascular Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Seok Whan (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Park, Jae Kil (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Mi Hyoung (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2019.08.26
  • Accepted : 2019.10.30
  • Published : 2020.06.05

Abstract

Background: Accurate intraoperative assessment of mediastinal lymph nodes is a critical aspect of lung cancer surgery. The efficacy and potential for upstaging implicit in these dissections must therefore be revisited in the current era of uniportal video-assisted thoracoscopic surgery (VATS). Methods: A retrospective study was conducted in which 544 patients with stage I (T1abc-T2a, N0, M0) primary lung cancer were analyzed. To assess risk factors for nodal upstaging and to limit any imbalance imposed by surgical choices, we constructed an inverse probability of treatment-weighted (IPTW) logistic regression model (in addition to non-weighted logistic models). We also evaluated risk factors for early locoregional recurrence using IPTW logistic regression analysis. Results: In the comparison of uniportal and multiportal VATS, the resected lymph node count (14.03±8.02 vs. 14.41±7.41, respectively; p=0.48) and rate of nodal upstaging (6.5% vs. 8.7%, respectively; p=0.51) appeared similar. Predictors of nodal upstaging included tumor size (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.12-2.70), carcinoembryonic antigen level (OR, 1.11; 95% CI, 1.04-1.18), and histologically confirmed pleural invasion (OR, 3.97; 95% CI, 1.89-8.34). The risk factors for locoregional recurrence within 1 year were found to be number of resected N2 nodes, age, and nodal upstaging. Conclusion: Uniportal and multiportal VATS appear similar with regard to accuracy and thoroughness, showing no significant difference in the extent of nodal dissection.

Keywords

References

  1. National Comprehensive Cancer Network. Non-small cell lung cancer: version 5 [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2019 [cited 2019 Jul 22]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
  2. Lin J, Fernandez F. Indications for invasive mediastinal staging for non-small cell lung cancer. J Thorac Cardiovasc Surg 2018;156:2319-24. https://doi.org/10.1016/j.jtcvs.2018.07.027
  3. Turner SR, Seyednejad N, Nasir BS. Patterns of practice in mediastinal lymph node staging for non-small cell lung cancer in Canada. Ann Thorac Surg 2018;106:428-34. https://doi.org/10.1016/j.athoracsur.2018.02.054
  4. Wang Y, Darling GE. Complete mediastinal lymph node dissection versus systematic lymph node sampling in surgical treatment of nonsmall cell lung cancer: do we have the answer? J Thorac Dis 2017;9:4169-70. https://doi.org/10.21037/jtd.2017.10.39
  5. Lardinois D, De Leyn P, van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92. https://doi.org/10.1016/j.ejcts.2006.08.008
  6. Goldstraw P. Report on the international workshop on intrathoracic staging: London, October 1996. Lung Cancer 1997;18:107-11. https://doi.org/10.1016/S0169-5002(97)00051-2
  7. Lewis RJ. The role of video-assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993;56:762-8. https://doi.org/10.1016/0003-4975(93)90975-N
  8. Gonzalez-Rivas D, de la Torre M, Fernandez R, Mosquera VX. Single-port video-assisted thoracoscopic left upper lobectomy. Interact Cardiovasc Thorac Surg 2011;13:539-41. https://doi.org/10.1510/icvts.2011.274746
  9. Wang BY, Tu CC, Liu CY, Shih CS, Liu CC. Single-incision thoracoscopic lobectomy and segmentectomy with radical lymph node dissection. Ann Thorac Surg 2013;96:977-82. https://doi.org/10.1016/j.athoracsur.2013.05.002
  10. Hirai K, Takeuchi S, Usuda J. Single-port video-assisted thoracic surgery for early lung cancer: initial experience in Japan. J Thorac Dis 2016;8(Suppl 3):S344-50.
  11. Liu CC, Shih CS, Pennarun N, Cheng CT. Transition from a multiport technique to a single-port technique for lung cancer surgery: is lymph node dissection inferior using the single-port technique? Eur J Cardiothorac Surg 2016;49 Suppl 1:i64-72.
  12. Mu JW, Gao SG, Xue Q, et al. A propensity matched comparison of effects between video assisted thoracoscopic single-port, two-port and three-port pulmonary resection on lung cancer. J Thorac Dis 2016;8:1469-76. https://doi.org/10.21037/jtd.2016.05.64
  13. Taylor MD, Nagji AS, Bhamidipati CM, et al. Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg 2012;93:1813-20. https://doi.org/10.1016/j.athoracsur.2012.03.031
  14. Fedor D, Johnson WR, Singhal S. Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. Surg Oncol 2013;22:156-61. https://doi.org/10.1016/j.suronc.2013.04.002
  15. Lee J, Lee JY, Choi JS, Sung SW. Comparison of uniportal versus multiportal video-assisted thoracoscopic surgery pulmonary segmentectomy. Korean J Thorac Cardiovasc Surg 2019;52:141-7. https://doi.org/10.5090/kjtcs.2019.52.3.141
  16. McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 2013;32:3388-414. https://doi.org/10.1002/sim.5753
  17. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies: version 2. Stat Med 2015;34:3661-79. https://doi.org/10.1002/sim.6607
  18. Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med 2013;32:2837-49. https://doi.org/10.1002/sim.5705
  19. Rocco G, Martin-Ucar A, Passera E. Uniportal VATS wedge pulmonary resections. Ann Thorac Surg 2004;77:726-8. https://doi.org/10.1016/S0003-4975(03)01219-0
  20. Heo W, Kang DK, Min HK, Jun HJ, Hwang YH. Feasibility and safety of single-port video-assisted thoracic surgery for primary lung cancer. Korean J Thorac Cardiovasc Surg 2017;50:190-6. https://doi.org/10.5090/kjtcs.2017.50.3.190
  21. Delgado Roel M, Fieira Costa EM, Gonzalez-Rivas D, Fernandez LM, Fernandez Prado R, de la Torre M. Uniportal video-assisted thoracoscopic lymph node dissection. J Thorac Dis 2014;6(Suppl 6):S665-8.
  22. Gonzalez-Rivas D, Paradela M, Fernandez R, et al. Uniportal video-assisted thoracoscopic lobectomy: two years of experience. Ann Thorac Surg 2013;95:426-32. https://doi.org/10.1016/j.athoracsur.2012.10.070
  23. Toker A, Ozyurtkan MO, Kaba E. Nodal upstaging: effects of instrumentation and three-dimensional view in clinical stage I lung cancer. J Vis Surg 2017;3:76. https://doi.org/10.21037/jovs.2017.04.05
  24. D'Cunha J, Herndon JE 2nd, Herzan DL, et al. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 2005;48:241-6. https://doi.org/10.1016/j.lungcan.2004.11.006
  25. Bertani A, Gonfiotti A, Nosotti M, et al. Nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry. J Thorac Dis 2017;9:2061-70. https://doi.org/10.21037/jtd.2017.06.12
  26. Tantraworasin A, Saeteng S, Siwachat S, et al. Impact of lymph node management on resectable non-small cell lung cancer patients. J Thorac Dis 2017;9:666-74. https://doi.org/10.21037/jtd.2017.02.90
  27. Bao F, Yuan P, Yuan X, Lv X, Wang Z, Hu J. Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer. J Thorac Dis 2014;6:1697-703. https://doi.org/10.3978/j.issn.2072-1439.2014.11.05
  28. Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol 2012;7:1246-51. https://doi.org/10.1097/JTO.0b013e31825871de